- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 17-04-2026: Press Release
17-04-2026 | 06:34 pm
17-04-2026 | 06:34 pm
Aurobindo Pharma received USFDA approval for Dextromethorphan Polistirex Oral Suspension, an OTC cough reliever. Targeting a US$ 138 million market, this product will launch in Q2FY27, expanding the company's US portfolio.
No comments yet. Be the first to comment!